MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Spyre Therapeutics, Inc. (NASDAQ: SYRE), formerly, Aeglea BioTherapeutics Inc. (NASDAQ: AGLE)*
*Key People: Aeglea
Parents
Spyre Therapeutics, Inc. (NASDAQ: SYRE), formerly, Aeglea BioTherapeutics Inc. (NASDAQ: AGLE)*
Children
2022: Aeglea culls workers, shifts pipeline focus after knockback by FDA
Anthony G. Quinn, Aeglea BioTherapeutics, Inc. - President, CEO & Director (2021)
CEO David Lowe
Charles N. York, Aeglea BioTherapeutics, Inc. - CFO & VP (2021)
Number of employees: 61 (2023)
The company has two employees and is operating out of the Austin Technology Incubator (2014)
Jumps
Finance & Acquisitions: Aeglea
Organization & Developments: Aeglea